The risk of liver cancer in autoimmune liver diseases.

导出 OA

翻译打印收藏纠错

作者： Ana,Lleo ^[1] ; Ynto S,de Boer ^[2] ; Rodrigo,Liberal ^[3] ; Massimo,Colombo ^[4]

作者单位： Department of Biomedical Sciences, Humanitas University, Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Via A. Manzoni 56, 20089 Rozzano (MI), Italy. ^[1] Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers - VU University Medical Center, The Netherlands. ^[2] Institute of Liver Studies, King's College London, UK. ^[3] Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy. ^[4]

关键词 autoimmune hepatitis autoimmune liver diseases cholangiocarcinoma hepatic cancer hepatocellular carcinoma primary biliary cholangitis primary sclerosing cholangitis

DOI 10.1177/1758835919861914

PMID 31320937

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Therapeutic advances in medical oncology

2019年11卷

1758835919861914页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The risk of liver cancer in autoimmune liver diseases.

Therapeutic advances in medical oncology

相似文献

Therapeutic advances in medical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The risk of liver cancer in autoimmune liver diseases.

Therapeutic advances in medical oncology

相似文献

Therapeutic advances in medical oncology

相关期刊

检索历史清除